Skip to main content
. 2018 May 24;8(5):e019868. doi: 10.1136/bmjopen-2017-019868

Table 3.

Overall cumulative period of using SGAs

Period of SGA use CKD cases (n=3411) Controls
(n=10 233)
OR (95% CI) P value AOR* (95% CI) P value
Cumulative SGA use
 Non-users 303 1304 1 1
 0<period≤ 90 177 552 1.38 (1.12 to 1.71) 0.0026 1.20 (0.95 to 1.51) 0.1247
 90<period≤ 180 92 241 1.65 (1.26 to 2.16) 0.0003 1.42 (1.06 to 1.91) 0.0208
 180<period≤ 1000 409 1271 1.39 (1.17 to 1.64) 0.0001 1.19 (0.99 to 1.43) 0.0654
 1000>period 2430 6865 1.53 (1.34 to 1.75) <0.0001 1.30 (1.13 to 1.51) 0.0004
Cumulative clozapine use (days)
 Non-users 2318 7215 1 1
 0<period≤ 90 183 351 1.63 (1.35 to 1.96) <0.0001 1.48 (1.20 to 1.81) 0.0002
 90<period≤180 49 140 1.09 (0.79 to 1.52) 0.6057 0.91 (0.63 to 1.32) 0.6281
 180<period≤1000 178 549 1.01 (0.85 to 1.20) 0.9091 0.94 (0.77 to 1.14) 0.5099
 1000>period 683 1978 1.08 (0.98 to 1.19) 0.1456 1.14 (1.02 to 1.27) 0.0181
Cumulative olanzapine use (days)
 Non-users 2046 6465 1 1
 0<period≤90 396 1018 1.23 (1.09 to 1.40) 0.0012 1.18 (1.02 to 1.35) 0.0225
 90<period≤180 156 344 1.44 (1.18 to 1.75) 0.0003 1.37 (1.11 to 1.70) 0.0039
 180<period≤1000 401 1038 1.22 (1.08 to 1.39) 0.0017 1.15 (1.00 to 1.32) 0.0561
 1000>period 412 1368 0.95 (0.85 to 1.08) 0.4401 1.05 (0.92 to 1.19) 0.4954
Cumulative quetiapine use (days)
 Non-users 1669 6198 1 1
 0<period≤90 399 967 1.54 (1.35 to 1.75) <0.0001 1.36 (1.19 to 1.57) <0.0001
 90<period≤180 147 356 1.54 (1.26 to 1.88) <0.0001 1.27 (1.02 to 1.58) 0.0358
 180<period≤1000 534 1180 1.69 (1.50 to 1.89) <0.0001 1.48 (1.30 to 1.68) <0.0001
 1000>period 662 1532 1.61 (1.45 to 1.79) <0.0001 1.44 (1.28 to 1.62) <0.0001
Cumulative zotepine use (days)
 Non-users 2292 7375 1 1
 0<period≤90 319 743 1.38 (1.20 to 1.59) <0.0001 1.26 (1.08 to 1.47) 0.0038
 90<period≤180 120 265 1.46 (1.17 to 1.82) 0.0008 1.27 (0.99 to 1.63) 0.0592
 180<period≤1000 310 770 1.30 (1.13 to 1.49) 0.0003 1.16 (1.00 to 1.36) 0.0572
 1000>period 370 1080 1.11 (0.97 to 1.26) 0.1240 1.00 (0.87 to 1.15) 0.9854
Cumulative risperidone use (days)
 Non-users 896 3056 1 1
 0<period≤90 396 1078 1.26 (1.09 to 1.44) 0.0012 1.14 (0.98 to 1.33) 0.0927
 90<period≤180 207 511 1.39 (1.16 to 1.66) 0.0003 1.26 (1.03 to 1.53) 0.0220
 180<period≤1000 733 2028 1.24 (1.10 to 1.38) 0.0002 1.12 (0.99 to 1.26) 0.0845
 1000<period 1179 3560 1.13 (1.03 to 1.25) 0.0148 1.10 (0.99 to 1.23) 0.0756

*Adjusted for diabetes mellitus, congestive heart failure, myocardial infarction, stroke, hyperlipidaemia, hypercholesterolaemia, hypertriglyceridaemia, hypertension and obesity.

AOR, adjusted OR; CKD chronic kidney disease; SGA, second-generation antipsychotic.